Related Experiment Video
Updated: May 21, 2025
14:51
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
3.1K
PLK1 Inhibition Induces Synthetic Lethality in Fanconi Anemia Pathway-Deficient Acute Myeloid Leukemia
Aditya S Sheth1,2, Ka-Kui Chan1, Sheng Liu2
1Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana.
Cancer Research Communications
|March 20, 2025
Summary
Fanconi anemia (FA) pathway mutations sensitize acute myeloid leukemia (AML) cells to PLK1 inhibitors. This identifies FA pathway mutations as biomarkers for predicting patient response to PLK1-targeted therapies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Acute myeloid leukemia (AML) has limited overall survival.
- PLK1 inhibitors show promise in AML but lack predictive biomarkers.
- Fanconi anemia (FA) pathway is frequently mutated in AML.
Purpose of the Study:
- To investigate the role of FA pathway disruption in AML sensitivity to PLK1 inhibition.
- To identify biomarkers for predicting response to PLK1 inhibitors in AML.
Main Methods:
- Investigated interactions between PLK1, FANCA, and FANCD2 in AML cells.
- Assessed the impact of PLK1 inhibition on FANCD2 recruitment and chromosome integrity.
- Utilized cell models with FA pathway deficiencies.
Main Results:
- FA pathway disruption sensitizes AML cells to PLK1 inhibition.
- PLK1 inhibition impairs FANCD2 recruitment to mitotic centromeres.
- PLK1 inhibition induces mitotic collapse in FANCA-deficient AML cells.
Conclusions:
- PLK1 inhibitors target specific vulnerabilities in FA pathway-deficient AML cells.
- FA pathway mutations can serve as predictive biomarkers for PLK1 inhibitor therapy in AML.
Related Concept Videos
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
01:31The Intrinsic Apoptotic Pathway
5.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.8K
02:37Restarting Stalled Replication Forks
5.7K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.7K
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K